|
2022
|
Invention
|
Process for preparing a benzoate salt of a 1-(3-aminopyrrolidine-1-carbonyl)-3,4-diphenylbenzene ... |
|
|
Invention
|
Combinatory therapy for cancer using biphenyl compound and immune checkpoint molecule regulator. ... |
|
|
Invention
|
Solid forms of salts of 4-[5-[(3s)-3-aminopyrrolidine-1-carbonyl]-2-[2-fluoro-4-(2-hydroxy-2-ethy... |
|
2021
|
Invention
|
Methods of treating ribonucleotide reductase-related diseases with a ribonucleotide reductase inh... |
|
|
Invention
|
Iap antagonist compounds and intermediates and methods for synthesizing the same. A compound of f... |
|
|
Invention
|
Methods for synthesizing anhydrous lactic acid. nnnX. The resulting reaction mixture is filtered ... |
|
|
Invention
|
Oligonucleotide analogues incorporating 5-aza-cytosine therein.
Oligonucleotide analogues are pr... |
|
2020
|
Invention
|
Methods of treating lsd1-related diseases and disorders with lsd1 inhibitors.
A method of treati... |
|
|
Invention
|
Methods of treating lsd1-related diseases and disorders with lsd1 inhibitors. A method of treatin... |
|
2019
|
Invention
|
Drug formulations. The invention provides derivatives of decitabine with superior chemical stabil... |
|
|
Invention
|
Oligonucleotide analogues incorporating 5-aza-cytosine therein. Oligonucleotide analogues are pro... |
|
|
Invention
|
Drug combinations.
The invention provides combinations of derivatives of decitabine and other ac... |
|
2015
|
Invention
|
Oligonucleotide analogues incorporating 5-aza-cytosine therein. Oligonucleotide analogs are provi... |
|
|
Invention
|
Pharmaceutical compositions for increasing the bioavailability of poorly soluble drugs. Pharmaceu... |
|
2014
|
Invention
|
Drug combinations. The invention provides combinations of derivatives of decitabine and other act... |
|
2012
|
Invention
|
Decitabine derivative formulations. The invention provides derivatives of decitabine with superio... |
|
|
G/S
|
Pharmaceutical compositions for treating cancer and immunologic diseases, namely, autoimmune dise... |
|
2011
|
G/S
|
Research and development services in the field of pharmaceuticals; providing medical and scientif... |
|
|
G/S
|
Research and development services in the field of
pharmaceuticals; providing medical and scienti... |
|
|
Invention
|
Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinas... |
|
2009
|
Invention
|
Oxo-imidazolyl compounds. Compounds represented by Formula I and II, or pharmaceutically acceptab... |
|
2005
|
G/S
|
Pharmaceutical compositions, namely, drugs for use in the treatment of cancer, autoimmune disease... |
|
|
Invention
|
Methods for treating hematological disorders through inhibition of dna methylation and histone de... |
|
|
Invention
|
Azacytosine analogs and derivatives. Compounds and compositions of azacytosine analogs and deriva... |
|
2004
|
Invention
|
Substituted tricyclic compounds as protein kinase inhibitors. Protein kinase inhibitors are discl... |
|
|
Invention
|
Kit for delivering decitabine in vivo. Pharmaceutical formulations, kits and vessels are provided... |
|
|
Invention
|
Method of administering decitabine. Pharmaceutical formulations, kits and vessels are provided fo... |
|
2003
|
G/S
|
Pharmaceutical compositions for treating cancer and immune disorders |
|
2001
|
Invention
|
Restore cancer-suppressing functions to neoplastic cells through dna hypomethylation. Composition... |
|
|
Invention
|
Method for administering camptothecins via injection of pharmaceutical composition comprising coa... |
|
|
Invention
|
Injectable pharmaceutical composition comprising coated particles of camptothecin. A pharmaceutic... |
|
1999
|
Invention
|
Pharmaceutical formulation. Compositions of matter comprising a substituted cyclodextrin and cyto... |
